Discovery of OR5V1: A Potential Drug Target and Biomarker (G81696)
Discovery of OR5V1: A Potential Drug Target and Biomarker
OR5V1 (6M1-21), a novel gene that encodes a protein with potential drug targets and biomarkers, has been identified in the scientific literature. OR5V1 is a gene located on chromosome 6, at position 121, and its protein is involved in various cellular processes, including cell adhesion, migration, and invasion.
The discovery of OR5V1 was made using a technique called transcriptomics, which involved the analysis of RNA from various cell types to identify new genes and potential drug targets. OR5V1 was identified based on its expression level in different cell types and its presence in a variety of tissues, including brain, heart, liver, and muscle.
OR5V1 is a member of the gene family known as the Rho GTPase (RhoA) gene family, which is involved in regulating various cellular processes, including cell adhesion, cytoskeletal organization, and signaling pathways. The RhoA gene family is a key regulator of the cell cycle and has been implicated in various diseases, including cancer, neurodegenerative diseases, and developmental disorders.
The OR5V1 gene has been shown to encode a protein that is involved in cell adhesion and migration. This protein is composed of 21 amino acid residues and has a calculated molecular weight of 19.4 kDa. OR5V1 has been shown to play a role in the formation of tight junctions, which are a type of cell-cell adhesion that is critical for maintaining tissue structure and function.
In addition to its role in cell adhesion and migration, OR5V1 has also been shown to be involved in the regulation of cell proliferation. This is consistent with its function as a drug target, as drugs that are able to inhibit the activity of OR5V1 may have potential therapeutic applications in cancer treatment.
The identification of OR5V1 as a potential drug target is further supported by its expression in various tissues and the results of experiments that have shown its ability to interact with certain drugs. For example, studies have shown that OR5V1 can be inhibited by the drug inhibitor PD98059, which is commonly used to treat cancer.
In conclusion, the discovery of OR5V1 (6M1-21) as a potential drug target and biomarker has significant implications for the development of new therapeutic approaches for a variety of diseases. Further research is needed to fully understand the role of OR5V1 in cellular processes and its potential as a drug target.
Protein Name: Olfactory Receptor Family 5 Subfamily V Member 1
Functions: Odorant receptor
More Common Targets
OR5W2 | OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1 | OR8J3 | OR8K1 | OR8K3 | OR8K5 | OR8S1 | OR8U1 | OR8U3 | OR8U8 | OR9A1P | OR9A2 | OR9A4 | OR9G1